Objective: Neurocognitive (NC) performance among older persons, including those living with HIV (PLWH), exhibits significant heterogeneity, suggesting subpopulations with differing profiles of NC impairment (NCI). Metabolic factors are associated with NCI, but their relationships to profiles of NCI are unknown. Methods: Participants (144 PLWH, 102 HIV-uninfected) aged 50+ years completed a standard neuropsychological battery assessing seven cognitive domains. Latent class analysis (LCA) was used to identify NCI profiles, which were examined against the Montreal Cognitive Assessment (MoCA). Multinomial regression was used to identify metabolic factors associated with classification.
INTRODUCTION
Despite the advent of combination antiretroviral therapy (cART), neurocognitive impairment (NCI) remains common among people living with HIV (PLWH). NCI among PLWH, also termed HIV-associated neurocognitive disorder (HAND), continues to be observed in up to half of PLWH in the cART era (1, 2) . The neurocognitive profile of HAND reflects considerable interindividual variability, with a wide range of performance in terms of severity and patterns of domain-specific cognitive dysfunction (3) . Although impairments in learning and executive functioning tend to be most prevalent in the cART era, many PLWH are also impaired in delayed recall, motor functioning, speed of information processing, and verbal fluency domains (2) . Thus, NCI among PLWH exhibits significant heterogeneity, and this variability in cognitive performance suggests that subpopulations of PLWH may differ in risk factors and mechanisms contributing to NCI.
NCI among PLWH may be mediated by a variety of neuropathological processes including chronic inflammation, incomplete HIV suppression in the central nervous system, neurotoxicity of antiretroviral drugs, and legacy effects following severe immunosuppression (i.e., nadir CD4 levels<200 ) (4) (5) (6) (7) . Additionally, with significant reductions in morbidity and mortality on cART, PLWH have improved longevity and are now experiencing age-related declines in cognition that are associated with neurodegenerative (such as Alzheimer's and Parkinson's) and cerebrovascular diseases (8) (9) (10) .
Multiple studies implicate metabolic syndrome (MetS), a constellation of related conditions (i.e., central obesity, hyperglycemia, dyslipidemia, and hypertension), with worse neurocognitive performance in PLWH, similar to the effects of MetS in the general population (10) (11) (12) (13) . However, older PLWH are at greater risk for developing metabolic conditions, Metabolic Risk and Neurocognitive Impairment 6 compared to age-and sex-matched controls (14) (15) (16) . Thus, MetS may promote neuronal injury and could account for the higher risk of neurocognitive deficits among older PLWH (17) . This notion of MetS-associated neurocognitive vulnerability among PLWH is supported by studies that have demonstrated that components of MetS heighten the risk for HAND and correlate with imaging markers of neurochemical abnormalities and neuroinflammation among older PLWH (11, 12, (18) (19) (20) .
Given variability in neurocognitive performance among PLWH and older adults, as well as individual differences in the presence of comorbidities that may impact neurocognitive performance, identifying neurocognitive profiles and their predictors is an important area of research. One approach that has been used to identify subgroups of individuals with similar patterns of neurocognitive performance is latent class analysis (LCA). LCA is an analytic method allowing the characterization of categorical unobserved (latent) variables from analyses of the structure of relationships among several observed variables. LCA has been utilized to uncover latent classes associated with Alzheimer's and Parkinson's diseases (21) (22) (23) . Although metabolic factors have been associated with NCI among PLWH and HIV-uninfected individuals, the relationship of metabolic risk factors to profiles of NCI and their differential contributions to NCI by HIV serostatus have not been examined. Thus, this project aimed to 1) determine profiles of NCI among PLWH and HIV-uninfected older adults using LCA and 2) compare the effect of HIV-infection on the relationship between metabolic syndrome risk factors and profiles of NCI.
We hypothesized that LCA would identify subgroups of PLWH and HIV-uninfected individuals that differ in profiles of NCI and that metabolic risk factors would have greater negative effects on cognition among PLWH. Specifically, we hypothesized that among PLWH, metabolic risk Metabolic Risk and Neurocognitive Impairment 7 factors would be associated with higher odds of classification in subgroups characterized by more extensive NCI.
METHODS

Participants
Data from 266 participants were selected from two HNRP-based studies of HIV and aging (Successfully Aging Seniors with HIV and Multi-Dimensional Successful Aging Among HIV-Infected Adults) at the University of California, San Diego. To enroll in these studies, participants had to be English-speaking and possessing the capacity to provide informed consent; an additional inclusion criterion for our analyses was age 50 years or older. Candidates were excluded if they had a history of conditions that might confound analyses, such as head injury with loss of consciousness for longer than 30 minutes, neurological disease with neurological or neuropsychiatric sequelae (e.g., stroke and seizure disorders), psychotic disorder, non-HIV degenerative brain diseases (e.g., diagnosis of dementia due to a condition other than HIV), or a severe learning disability (e.g., Wide Range Achievement Test Reading score <70).
Measures
Neurocognitive Functioning
Participants completed a comprehensive neurocognitive test battery covering seven ability domains (verbal fluency, executive functioning, speed of information processing, verbal and visual learning, verbal and visual delayed recall/memory, working memory, and motor Metabolic Risk and Neurocognitive Impairment 8 skills) (24) . Following established procedures, Domain Deficit Scores (DDS) were computed from conversions of T-scores, demographically-corrected for the effects of age, education, sex and ethnicity (1, 25) . Previous studies have shown a balance of sensitivity and specificity in identifying NCI using DDS cutoffs of > 0.5 (25) ; thus, participants were classified with NCI vs.
no NCI in each of the seven domains using this DDS threshold. Additionally, deficit scores were averaged across all tests in the battery to create a Global Deficit Score (GDS) for each individual which was similarly dichotomized into ratings of impairment (GDS≥ 0.5) vs. no impairment (GDS < 0.5) (25, 26) .
Metabolic Comorbidities
Metabolic risk factors (i.e., dyslipidemia (elevated triglycerides and/or low HDL), central obesity (i.e., large waist circumference), diabetes, and hypertension) were determined from a combination of self-report (e.g., history of diabetes and/or hypertension) and objective laboratory (i.e., phlebotomy and anthropomorphic) assessments. Metabolic risk factors examined were consistent with the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) criteria for metabolic risk (27, 28) . The NCEP ATP III panel defines metabolic risk as 1) large waist circumference (> 102 cm [40 in] for men, 88 cm [35 in] for women), 2) elevated triglycerides (≥150 mg/dl) or prescription, 3) low HDL cholesterol (40 mg/dl in men, 50 mg/dl in women) or prescription, 4) hypertension (>130mmHg systolic or >85 mmHg diastolic) or prescription, and 5) elevated fasting glucose (≥100 mg/dl) or prescription. Thus, if participants reported receiving a prior medical diagnosis, reported prescription of drug treatment for a condition, or if they had laboratory measurements for any of the conditions at or above NCEP ATP III thresholds, they were considered positive for that metabolic risk factor. Finally, to obtain Metabolic Risk and Neurocognitive Impairment 9 a diagnosis of MetS, indicators of MetS were summed into a composite variable, which ranged from 0 to 5, and an NCEP ATP III diagnosis of MetS applied if they had 3 or more of the factors.
Alternative Measure of Cognitive Functioning
In addition to completing the standard neuropsychological battery, participants were also assessed using the Montreal Cognitive Assessment (MoCA), a well-validated neurocognitive screener for clinical geriatric populations (29) .
Potential Covariates
In addition to demographics, the following variables that have previously been associated with neurocognitive performance or MetS were considered as potential covariates affecting latent classification:
Premorbid Functioning
All participants completed the reading subtest of the Wide Range Achievement Test-IV (WRAT-IV-Reading) (30) . Single-word reading tests, such as the WRAT-IV, are common performance-based tools for estimating premorbid verbal IQ and the WRAT-IV has shown strong test-retest reliability as a measure of premorbid functioning (31, 32) 
Psychiatric, Behavioral, and Medical Conditions
The presence/absence of lifetime mood (e.g., major depressive disorder) and substance use disorders (e.g., alcohol use disorder) were evaluated with the Composite International Metabolic Risk and Neurocognitive Impairment 10 Diagnostic Interview (CIDI v.2.1), using diagnostic criteria based on the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (33) .
Hepatitis C and Tobacco Smoking
Hepatitis-C (HCV) infection was diagnosed by enzyme-linked immunosorbent assay and lifetime smoking was obtained by participant self-report of tobacco smoking.
HIV Disease and Treatment Characteristics.
For PLWH, disease and treatment characteristics were collected by participant self-report and laboratory assessment. In particular, PLWH provided information about their estimated duration of HIV infection, length on current and previous ART regimens, and nadir CD4+ T-cell counts. Blood was also collected and clinical assays (e.g., complete blood count) performed by a Clinical Laboratory Improvement Amendments (CLIA)-certified laboratory at the UCSD Medical Center. Current CD4+ T-cell count was measured by flow cytometry and HIV RNA levels in blood were measured by reverse transcriptase-polymerase chain reaction with a lower limit of quantitation (LLQ) at 50 viral copies/mL.
Data Analysis
LCA was used to estimate the number of classes that best-captured similar patterns of DDS across the seven domains of neurocognitive performance. To determine the number of categorical latent classes underlying the observed patterns, several models with increasing numbers of latent classes were estimated. The best-fitting model was selected based on four indices: the Bayesian Information Criteria (BIC), Akaike Information Criteria (AIC), entropy, Metabolic Risk and Neurocognitive Impairment 11 and the bootstrapped likelihood ratio test (BLRT). For each model with k number of classes, the best log-likelihood was replicated in order to avoid convergence at a local maximum.
Additionally, in log-likelihood ratio tests to examine model fit, the log-likelihood for the null model with k-1 classes was verified as being equal to the best log-likelihood value of the previously-tested model with one fewer class (34) .
Once the optimum number of classes was identified, the final LCA model was adjusted for relevant covariates (i.e., any of the previously-described potential covariates that were correlated with latent classes at p< 0.10). Convergent validity of these covariate-adjusted classes was examined by comparisons of the means of scores on the MoCA across each of the identified latent classes using Wald  2 -tests; corrections for Type I errors in multiple comparisons were made using the Benjamini-Hochberg procedure (35) . The extent to which HIV infection moderated the association between metabolic disease characteristics and group membership in the identified latent classes was determined using multinomial regression.
In all regressions and Wald tests, a "3-step" approach, in which class membership was assigned using observed DDS categorizations and relevant covariates prior to the inclusion in the model of outcome or predictors variables was used in order to prevent these auxiliary factors from altering the structure of latent classes and influencing final class membership (36, 37) . All LCA analyses were conducted using Mplus version 7.4 using robust maximum likelihood estimation (MLR) that is robust to missing data and non-normal distributions of outcomes (38) .
RESULTS
Prevalence of demographic and metabolic risk factors
By the combined self-report and/or NCEP ATP III criteria, 162 (65.9%) participants had hypertension, 91 (37%) had central obesity, 173 (70.3%) had dyslipidemia, 42 (17.1%) had diabetes, and 93 (37.8%) had MetS. Of these, 46.3% of participants who were categorized as hypertensive reported prescription of antihypertensive medication, 69.0% of those categorized as having diabetes reported prescription of diabetes medication, and 48.6% of those with dyslipidemia were on lipid-lowering medication. With regards to demographics, participants were on average 57.96 years old (SD= 6.10 years), with 14.43 years of education (SD= 2.55 years), and were predominantly non-Hispanic white (72.4%) and male (79.3%). Further detailed descriptive statistics of the sample, including summaries of study variables are presented in Table 1 . Table 2 reports numbers of individuals assigned to latent classes and the indices of fit for LCA models that were tested separately among PLWH and HIV-uninfected participants. Table 4 reports results of the multinomial regression of latent classes on metabolic risk factors. In all analyses, the interaction between metabolic risk and HIV serostatus was included in order to examine the differential effects by HIV serostatus. When an interaction was not significant, that term was discarded in order to interpret the main effects. (29) . Furthermore, the average MoCA scores of individuals in Class 1Multidomain NCI was lower than that of individuals in Class 2Learning & Recall NCI, suggesting that the widespread pattern of NCI observed in Class 1Multidomain NCI paralleled a greater degree of clinical impairment than in the other two classes.
Identification of Number of Latent Classes
Convergent validity of Latent Classes
Predictors of Classification
Post-hoc analyses
Previous studies have described the domain-specific patterns of NCI in PLWH as "spotty" and this study confirmed findings of variable patterns of NCI among PLWH (1). We found that three distinct patterns of NCI predominate among PLWH and that they are similar to profiles of NCI among HIV-uninfected individuals; thus, NCI phenotypes in HIV-infection may not be unique and may reflect shared or similar pathogenic mechanisms. Although the patterns of impairment and interpretations of classes were similar across PLWH and HIV-uninfected samples, some domains within similar pairs of classes appeared to be more vulnerable to impairment among PLWH. In particular, in Class 1Multidomain NCI, impaired speed of information processing tended to be more prevalent among PLWH, while learning and working memory were more greatly affected in Class 2Learning & Recall NCI, and delayed recall appeared more affected in Class 3NC Unimpaired. This greater impairment among PLWH in speed of information processing, learning, recall, and working memory is consistent with preferential involvement of frontostriatal brain regions (39) .
Previous work has also used clustering approaches to identify profiles of neurocognitive performance among PLWH and HIV-uninfected individuals and identified varying numbers of classes (21, (40) (41) (42) (43) (44) . Some of the differences in these studies may be a function of the clustering method (e.g., cluster analysis vs. LCA), sample size, the nature of indicators of neuropsychological performance, and populations at risk for NCI. Thus, the number of classes obtained in this study may differ from those previously identified in other studies. However, Metabolic Risk and Neurocognitive Impairment 18 despite variability in the number of estimated classes underlying neurocognitive performance, clusters of NC performance similar to the three classes obtained in this study have previously been observed. Indeed, other studies have found evidence of classes of individuals with few deficits, classes with some exhibiting global NCI, and others with NCI that is primarily amnestic, suggesting the ubiquity of these patterns of NCI across different samples (21, (41) (42) (43) .
When predictors of classification were examined, diabetes was found to be associated with multidomain NCI, regardless of HIV status. Additionally, PLWH classified as having widespread multidomain NCI were more likely to have hypertension, dyslipidemia, and central obesity. These findings, that HIV infection can amplify the detrimental effects of metabolic risk factors on cognition, are consistent with those of other studies that have similarly noted the potentiation of neurocognitive insults in the context of HIV infection (14, 17) . Given this, there may be a need for interventions that focus on supporting the cardio-metabolic well-being of PLWH that may limit or reverse declines in cognition. Additionally, strategies to further promote neurocognitive well-being may need to be applied. A good example of this may be of the provision of "cognitive prescriptions" by medical professionals to their patients (i.e., advocating physical activity and engagement in cognitively-demanding activities, as well as promoting adequate nutrition and sleep) in order to maintain or improve cognitive health (45) . Such encouragement of healthy behaviors would stand to benefit all individuals and PLWH in particular. Furthermore, given documented low rates of diagnosis of metabolic conditions and prescription of medications to manage them within the general population, facilitating increased access and engagement in medical care will also have significant implications for individual well-being and public health (46) . Second, we examined the convergent validity of latent classification against the MoCA and found evidence to suggest that differences in the degree of severity of NCI implied by the three latent classes corresponded to differences in cognitive dysfunction captured by this standardized external measure. However, as the MoCA is a brief screener, it is less comprehensive and almost certainly less sensitive to HAND and other forms of NCI than the standard neuropsychological test battery that was utilized in LCA analyses. Given this, more comprehensive measures should be considered in future work to assess construct validity.
Furthermore, our analyses are cross-sectional; thus, we are unable to determine whether these latent classes have implications for the future course of neurocognitive health. Longitudinal studies are needed to examine if metabolic risk factors predict future cognitive impairment, including the development of dementia, and whether they may speak to the disentanglement of HAND from Alzheimer's among PLWH (47) . Future studies should also examine the effects of sex and racial /ethnic differences on patterns of performance on neuropsychological tests among Metabolic Risk and Neurocognitive Impairment 20 older individuals and combine these studies with neuroimaging and the assessment of biomarkers.
In summary, this study utilized LCA to model heterogeneity in the neurocognitive performance of older adults living with and without HIV infection and related profiles of NCI to metabolic risk factors. PLWH with metabolic risk factors were at increased risk of multi-domain NCI and early intervention to reduce these metabolic risk factors may improve the neurocognitive outcomes of PLWH. However, additional longitudinal observational studies, coupled with imaging and biomarkers, could help to inform and target interventional approaches. 
